Literature DB >> 32049385

On the estimation of average treatment effects with right-censored time to event outcome and competing risks.

Brice Maxime Hugues Ozenne1,2, Thomas Harder Scheike1, Laila Staerk3, Thomas Alexander Gerds1,4.   

Abstract

We are interested in the estimation of average treatment effects based on right-censored data of an observational study. We focus on causal inference of differences between t-year absolute event risks in a situation with competing risks. We derive doubly robust estimation equations and implement estimators for the nuisance parameters based on working regression models for the outcome, censoring, and treatment distribution conditional on auxiliary baseline covariates. We use the functional delta method to show that these estimators are regular asymptotically linear estimators and estimate their variances based on estimates of their influence functions. In empirical studies, we assess the robustness of the estimators and the coverage of confidence intervals. The methods are further illustrated using data from a Danish registry study.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  Cox regression model; hazard ratio; probabilistic index; relative risk; survival analysis

Mesh:

Year:  2020        PMID: 32049385     DOI: 10.1002/bimj.201800298

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  5 in total

1.  Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.

Authors:  Emil L Fosbøl; Jawad H Butt; Lauge Østergaard; Charlotte Andersson; Christian Selmer; Kristian Kragholm; Morten Schou; Matthew Phelps; Gunnar H Gislason; Thomas A Gerds; Christian Torp-Pedersen; Lars Køber
Journal:  JAMA       Date:  2020-07-14       Impact factor: 56.272

2.  Estimating the Effectiveness of Rotavirus Vaccine Schedules.

Authors:  Anne M Butler; Alexander Breskin; John M Sahrmann; M Alan Brookhart
Journal:  Epidemiology       Date:  2021-07-01       Impact factor: 4.860

3.  Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study.

Authors:  Jawad Haider Butt; Thomas Alexander Gerds; Morten Schou; Kristian Kragholm; Matthew Phelps; Eva Havers-Borgersen; Adelina Yafasova; Gunnar Hilmar Gislason; Christian Torp-Pedersen; Lars Køber; Emil Loldrup Fosbøl
Journal:  BMJ Open       Date:  2020-12-04       Impact factor: 2.692

4.  Increased vulnerability to COVID-19 in chronic kidney disease.

Authors:  N Carlson; K-E Nelveg-Kristensen; E Freese Ballegaard; B Feldt-Rasmussen; M Hornum; A-Lise Kamper; G Gislason; C Torp-Pedersen
Journal:  J Intern Med       Date:  2021-02-10       Impact factor: 13.068

5.  Glycated haemoglobin levels among 3295 hospitalized COVID-19 patients, with and without diabetes, and risk of severe infection, admission to an intensive care unit and all-cause mortality.

Authors:  Amna Alhakak; Jawad H Butt; Thomas A Gerds; Emil L Fosbøl; Ulrik M Mogensen; Johanna Krøll; Jannik L Pallisgaard; Gunnar H Gislason; Christian Torp-Pedersen; Lars Køber; Peter E Weeke
Journal:  Diabetes Obes Metab       Date:  2021-12-05       Impact factor: 6.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.